2. Academic Validation
  3. Design and synthesis of tetrazole tethered quinazoline derivatives via azide-isocyanide cross-coupling reaction: Exploring the utility as anticancer agents via the SRC kinase inhibition in breast cancer

Design and synthesis of tetrazole tethered quinazoline derivatives via azide-isocyanide cross-coupling reaction: Exploring the utility as anticancer agents via the SRC kinase inhibition in breast cancer

  • Bioorg Chem. 2025 Sep:164:108844. doi: 10.1016/j.bioorg.2025.108844.
Lang Zou 1,  Umesh Prasad Yadav 2,  Arockia Babu Marianesan 3,  Roshan Kumar 4,  Thakur Gurjeet Singh 5,  Akash Verma 6,  Glowi Alasiri 7,  Mohammad Fareed 8,  Prawez Alam 9,  Elagandhula Sathish 10,  Yaxun Huang 11
Affiliations

Affiliations

  • 1 Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.
  • 2 Department of Hematologic Malignancies Translational Science, City of Hope Medical Center, Duarte, California 91010, USA.
  • 3 Institute of Pharmaceutical Research, GLA University, Mathura, 17 Km Stone, National Highway #2, Delhi-Mathura Road, India.
  • 4 Department of Microbiology, Graphic Era (Deemed to be University), Clement Town, Dehradun 248002, India.
  • 5 Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
  • 6 Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad 244001, U.P, India.
  • 7 Department of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
  • 8 Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box 71666, Riyadh 13713, Saudi Arabia.
  • 9 Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
  • 10 GITAM School of Pharmacy, GITAM (Deemed to be) University, Hyderabad, India.
  • 11 Department of Liver Transplantation, The Second Xiangya Hospital, Central South University, Changsha 410011, China; Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, California 91010, USA. Electronic address: yaxunhuang@csu.edu.cn.
PMID: 40834454 DOI: 10.1016/j.bioorg.2025.108844
Abstract

Kinases, particularly non-receptor tyrosine kinases (nRTK), are vital growth factors that determine the fate of numerous cancers, including breast Cancer (BC). One such nRTK is c-Src, which plays a profound role in BC, is associated with BC development and metastasis, and induces resistance to Cancer therapeutics. Considering the critical role of c-Src in BC outcome, we herein rationally designed and developed the tetrazole tethered quinazoline derivatives, considering the pharmacophoric feature of the catalytic domain of c-Src. The synthesis via the azide-isocyanide cross-coupling reaction led to the development of 11 compounds (3a-3 k) in good to high yields. Biological analysis revealed that all the compounds possessed Anticancer potential against BC cells. Among them, Compounds 3e and 3 g showed nanomolar range activity in the employed cells, that is, MDAMB-231 (IC50: 0.826 and 0.812 nM), T47D (IC50: 0.973 and 1003 nM), and MCF-7 (IC50:0.654 and 0.568 nM), in comparison to the positive control. These compounds were found to be nontoxic to normal cells. The target delineation studies on cSrc revealed the potent and dose-dependent inhibition of the kinase activity by the selected compounds 3e (IC50: 410 nM) and 3 g (IC50: 302 nM) compared to the employed positive control bosutinib (IC50: 446 nM). The analysis was rationally corroborated by the in-silico analysis, particularly the molecular docking and dynamics. Besides this, the secondary Anticancer mechanisms revealed that the compounds 3e and 3 g could upsurge the ROS levels in the Cancer cells, alter the mitochondrial membrane (depolarization), induce cell death primarily via Apoptosis, and halt the Cancer cell cycle beyond the G1 phase.

Keywords

Anticancer; Breast cancer; Cell death; Drug discovery; Kinases; Molecular modeling.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z